Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology International"
DOI: 10.1007/s00296-019-04348-y
Abstract: Familial Mediterranean Fever (FMF), the most common monogenic inflammatory disease, is mainly treated by oral Colchicine. However, 5% of patients are considered non-responders and, therefore, candidates for biologic therapy. Intravenous (IV) Colchicine treatment has been… read more here.
Keywords: familial mediterranean; safety; colchicine; intravenous colchicine ... See more keywords